Clinical Trial: Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07102901) titled 'Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma' on July 29.

Brief Summary: This is a multicenter, phase 2, open label study to evaluate safety, tolerability and efficacy of SHR2554 combined with other anti-tumor treatments in patients with advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Advanced Gastric Cancer Metastatic Gastric Cancer Gastroesophageal Junction Adenocarcinoma

Intervention: DRUG: SHR2554 Tablets

Oral SHR2554 tablets.

DRUG: SHR-A1811 Inj...